Loading...
Development and Use of Integral Assays in Clinical Trials
Clinical trials that include integral biomarkers to determine eligibility, assign treatment or assess outcome must employ robust assays to measure the molecular analyte of interest. The decision to develop a biomarker assay into a test suitable for use in humans should be driven by clinical need, i....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3307146/ https://ncbi.nlm.nih.gov/pubmed/22422406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-2202 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|